Is Moderna's COVID-19 vaccine finally on the way for kids under six?
The company said Wednesday its coronavirus vaccine generated a strong immune response in children between six months and six years old, NBC News reports. The vaccine was given to kids at a lower dose than is given to adults.
The data comes from a trial that consisted of about 6,900 children, and Moderna said the vaccine generated a "robust neutralizing antibody response" both in kids between six months and under two years old and kids between two and six years old. The "majority of adverse events were mild or moderate," the company also said.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
"We believe these latest results from the KidCOVE study are good news for parents of children under 6 years of age," Moderna CEO Stéphane Bancel said. "We now have clinical data on the performance of our vaccine from infants six months of age through older adults. Given the need for a vaccine against COVID-19 in infants and young children we are working with the U.S. FDA and regulators globally to submit these data as soon as possible."
The vaccine was about 43.7 percent effective against the Omicron variant in children between six months and two years old and 37.5 percent effective in kids between two and five years old.
Moderna now plans to seek emergency use authorization for the vaccine in kids under six from the FDA. NBC medical correspondent John Torres said on the Today show this FDA approval will be a "huge game-changer," and he speculated it could happen within the next month or so. "That's going to let us get back to more normal lives," Torres added.
-
Israel: Losing the American publicFeature A recent poll finds American support for Israel's military action in Gaza has fallen from 50% to 32%
-
Unmaking AmericansFeature Trump is threatening to revoke the citizenship of foreign-born Americans. Could he do that?
-
EPA: A bonfire of climate change regulationsFeature The Environmental Protection Agency wants to roll back its 'endangerment finding,' a ruling that lets the agency regulate carbon emissions
-
RFK Jr. shuts down mRNA vaccine funding at agencySpeed Read The decision canceled or modified 22 projects, primarily for work on vaccines and therapeutics for respiratory viruses
-
Cytomegalovirus can cause permanent birth defectsThe Explainer The virus can show no symptoms in adults
-
Measles cases surge to 33-year highSpeed Read The infection was declared eliminated from the US in 2000 but has seen a resurgence amid vaccine hesitancy
-
Kennedy's vaccine panel signals skepticism, changeSpeed Read RFK Jr.'s new vaccine advisory board intends to make changes to the decades-old US immunization system
-
Kennedy ousts entire CDC vaccine advisory panelspeed read Health Secretary RFK Jr. is a longtime anti-vaccine activist who has criticized the panel of experts
-
RFK Jr. scraps Covid shots for pregnant women, kidsSpeed Read The Health Secretary announced a policy change without informing CDC officials
-
New FDA chiefs limit Covid-19 shots to elderly, sickspeed read The FDA set stricter approval standards for booster shots
-
US overdose deaths plunged 27% last yearspeed read Drug overdose still 'remains the leading cause of death for Americans aged 18-44,' said the CDC
